Strain Name:

MRL/MpJ

Stock Number:

000486

Availability:

Level 4

Description

Strain Information

Type Inbred Strain;
Additional information on Inbred Strains.
Visit our online Nomenclature tutorial.
Mating SystemSibling x Sibling         (Female x Male)
Specieslaboratory mouse
H2 Haplotypek
GenerationF137 (03-JAN-08)

Appearance
albino, unaffected
Related Genotype: a/a Tyrc/Tyrc Fas+/Fas+

Description
The MRL/MpJ mice are large but docile to the point that males rarely fight. They are the parent and control strain for for MRL/MpJ-Faslpr (Stock Nos. 000485, 006825). Despite carrying the normal Fas gene, MRL/MpJ mice also exhibit autoimmune disorders, but symptoms are manifested much later in life compared to those the MRL/MpJ-Faslpr mice. Starting at about three months of age, levels of circulating immune complexes rise greatly in the MRL-Faslpr mouse but not in the wildtype control, MRL/MpJ. Also beginning at 3 months Faslpr mice exhibit very severe poliferative glomerulonephritis, whereas in the MRL/MpJ controls usually only mild glomerular lesions are detected. MRL/MpJ inbred female typically die at 73 weeks of age and males die at 93 weeks. This compares to a lifespan of 17 weeks in the female and 22 weeks for males in the mouse homozygous for Faslpr. See MRL/MpJ-Faslpr (Stock No. 000485) for additional information. As a strain developed as the control for MRL/MpJ-Faslpr, MRL/MpJ mice are useful in the study of their comparable defects and diseases.

MRL/MpJ, and one of its ancestral strains LG/J, display heightened wound healing relative to a panel of other inbred strains. At 4 weeks post-injury, 2mm ear punch wounds heal to 0-0.4mm in MRL/MpJ mice but are still 1.2-1.6mm in C57BL/6 mice. At 15 days post-injury C57BL/6 show a maximal closure of 30% reduction in ear hole size while MRL show 85% reduction. The process of healing in MRL/MpJ mice is faster, more complete, showed increased swelling, angiogenesis, fibroblast migration, extracellular matrix deposition, and decreased scarring and fibrosis. Additionally, hair follicles and accompanying sebaceous glands regenerate to a much greater degree. The other ancestral strains of MRL/MpJ (C3H, C57BL/6, and AKR) do not display this enhanced healing. Bone marrow transplantation shows that the MRL/MpJ healing phenotype does not readily transfer with bone marrow and remains in the irradiated host tissues. Enhanced healing of cardiac wounds has also been reported in MRL/MpJ mice. In this model, a very high mitotic index (10-20%) is found, similar to that seen in non-mammalian tissue regeneration. Using F2 and backcross mapping of MRL/MpJ-Faslpr x B6 progeny McBrearty et al. identified multiple wound healing QTLs, Heal2 and Heal3 ,on MRL/MpJ chromosome 13 in the region of D13Mit115 and D13Mit129 respectively; Heal5 on MRL/MpJ chromosome 12 in the region of D12Mit233; Heal1 on chromosome 8 of C57BL/6 in the region of D8Mit211; and a highly suggestive locus on MRL/MpJ chromosome 7 in the region of D7Mit220. In crosses between MRL/MpJ x SJL/J, Masinde et al. identified 10 QTL for wound healing, confirming and extending the findings of McBrearty et al. Chromosomes 1, 3, 6, and 13 each have a single QTL with that on chromosome 13 being statistically suggestive but not significant, while chromosomes 4, 7, and 9 each have two statistically significant QTLs. (Clark et al., 1998; Leferovich et al., 2001; Kench et al., 1999; McBrearty et al., 1998; Masinde et al., 2001.)

Microarray analysis and SELDI ProteinChip analysis identified multiple genes and proteins that have varied expression in the ear punch wounds of MRL/MpJ-Faslpr versus C57BL/6. The changes in expression patterns suggest that in MRL/MpJ mice there is less of an inflammatory response and an earlier transition into tissue repair than is seen in C57BL/6. (Li et al., 2000 and 2001.)

Blankenhorn et al. found that MRL/MpJ females heal faster and more completely than males. Some Heal QTLs are sexually dimorphic with Heal2, 3, 7, 8, 10, and 11 having greater effects in males and Heal4, 5, and 9 having greater effects in females. Castration improves wound healing in MRL/MpJ males to nearly the degree seen in females, but ovariectomy does not improve the degree of healing seen in MRL/MpJ females. (Blankenhorn et al., 2003)

Relative to B10.D2nSnJ mice, MRL/MpJ mice have decreased Neutrophil accumulation in the bronchiolar lavage in response to LPS infusion, and tests using bone marrow chimeras reveal= that the pulmonary inflammatory response transfers with bone marrow. Transforming growth factor beta 1 autologous induction is reduced in MRL/MpJ splenocytes while macrophages show a reduction in the transforming growth factor beta 1 induction of interleukin 1 beta and tumor necrosis factor alpha production but no significant reduction in transforming growth factor beta 1 production. (Kench et al., 1999.)

Development
The MRL/MpJ lymphoproliferation wildtype strain was generated from a series of crosses with strains C57BL/6J (0.3%), C3H/HeDi (12.1%), AKR/J (12.6%) and LG/J (75%) and then followed by inbeeding. The composite genome distribution is indicated in parenthesis. Current generation of inbreeding is F98+. During development of this strain, at F12, the spontaneous mutation Faslpr was found. MRL/MpJ-Faslpr (Stock Nos. 000485 and 006825) and the MRL/MpJ control are kept congenic with each other by backcrosses to the MRL/MpJ wildtype every 5-10 inbred generations.

Control Information

   
   This strain is a control for 000485 MRL/MpJ-Faslpr/J and 002983 MRL.CBAJms-Faslpr-cg/J.
 
  Considerations for Choosing Controls

Additional Web Information

Genetic Quality Control Annual Report
JAX® NOTES, Fall 2008; 511. "Healer" JAX® Mice strain can regenerate cartilage.
JAX® NOTES, January 1988; 432. Arthritis Models in the Mouse.

Phenotype

Phenotype Information

View Phenotypic Data

View Mammalian Phenotype Terms

Mammalian Phenotype Terms
      assigned by genotype

  • immune system phenotype
  • pancreas inflammation (MGI Ref ID J:1376)
    • spontaneous pancreatitis in females over 22 weeks of age, with diffuse mononuclear infiltrate and destruction of acini and replacement of parenchyma with adipose, but pancreatic islets are unaffected
    • incidence in females is 74% at 34-38 weeks of age; less severe in males, incidence in males is 40% at 46-50 weeks of age
    • disease can be transferred with splenocytes from older females into younger, unaffected female but not male hosts, but disease can not be transferred with serum
    • chronic pancreas inflammation (MGI Ref ID J:1376)
  • endocrine/exocrine gland phenotype
  • pancreas inflammation (MGI Ref ID J:1376)
    • spontaneous pancreatitis in females over 22 weeks of age, with diffuse mononuclear infiltrate and destruction of acini and replacement of parenchyma with adipose, but pancreatic islets are unaffected
    • incidence in females is 74% at 34-38 weeks of age; less severe in males, incidence in males is 40% at 46-50 weeks of age
    • disease can be transferred with splenocytes from older females into younger, unaffected female but not male hosts, but disease can not be transferred with serum
    • chronic pancreas inflammation (MGI Ref ID J:1376)
  • digestive/alimentary phenotype
  • pancreas inflammation (MGI Ref ID J:1376)
    • spontaneous pancreatitis in females over 22 weeks of age, with diffuse mononuclear infiltrate and destruction of acini and replacement of parenchyma with adipose, but pancreatic islets are unaffected
    • incidence in females is 74% at 34-38 weeks of age; less severe in males, incidence in males is 40% at 46-50 weeks of age
    • disease can be transferred with splenocytes from older females into younger, unaffected female but not male hosts, but disease can not be transferred with serum
    • chronic pancreas inflammation (MGI Ref ID J:1376)

    Genes & Alleles

    Gene & Allele Information

    Currently there are no related genes or alleles for this strain.

    Genotyping

    Genotyping Information

    Genotyping Protocols

    Generic Y-Chromosome, STD PCR, vers. 1

    Helpful Links

    Genotyping resources and troubleshooting

    References

    References

    Selected Reference(s)

    Clark LD; Clark RK; Heber-Katz E. 1998. A new murine model for mammalian wound repair and regeneration. Clin Immunol Immunopathol 88(1):35-45. [PubMed: 9683548]  [MGI Ref ID J:48937]

    Hewicker M; Kromschroder E; Trautwein G. 1990. Detection of circulating immune complexes in MRL mice with different forms of glomerulonephritis. Z Versuchstierkd 33(4):149-56. [PubMed: 2238887]  [MGI Ref ID J:109933]

    Kanno H; Nose M; Itoh J; Taniguchi Y; Kyogoku M. 1992. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol 89(1):68-73. [PubMed: 1352748]  [MGI Ref ID J:1376]

    Kench JA; Russell DM; Fadok VA; Young SK; Worthen GS; Jones-Carson J; Henson JE; Henson PM; Nemazee D. 1999. Aberrant wound healing and TGF-beta production in the autoimmune-prone MRL/+ mouse. Clin Immunol 92(3):300-10. [PubMed: 10479535]  [MGI Ref ID J:57718]

    Koh JS; Wang Z; Levine JS. 2000. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus J Immunol 165(8):4190-201. [PubMed: 11035051]  [MGI Ref ID J:65106]

    Leferovich JM; Bedelbaeva K; Samulewicz S; Zhang XM; Zwas D; Lankford EB; Heber-Katz E. 2001. Heart regeneration in adult MRL mice. Proc Natl Acad Sci U S A 98(17):9830-5. [PubMed: 11493713]  [MGI Ref ID J:109867]

    Li X; Mohan S; Gu W; Baylink DJ. 2001. Analysis of gene expression in the wound repair/regeneration process. Mamm Genome 12(1):52-9. [PubMed: 11178744]  [MGI Ref ID J:68684]

    Li X; Mohan S; Gu W; Miyakoshi N; Baylink DJ. 2000. Differential protein profile in the ear-punched tissue of regeneration and non-regeneration strains of mice: a novel approach to explore the candidate genes for soft-tissue regeneration Biochim Biophys Acta 1524(2-3):102-9. [PubMed: 11113556]  [MGI Ref ID J:66437]

    Masinde GL; Li X; Gu W; Davidson H; Mohan S; Baylink DJ. 2001. Identification of Wound Healing/Regeneration Quantitative Trait Loci (QTL) at Multiple Time Points that Explain Seventy Percent of Variance in (MRL/MpJ and SJL/J) Mice F(2) Population. Genome Res 11(12):2027-33. [PubMed: 11731492]  [MGI Ref ID J:73197]

    McBrearty BA; Clark LD; Zhang XM; Blankenhorn EP; Heber-Katz E. 1998. Genetic analysis of a mammalian wound-healing trait. Proc Natl Acad Sci U S A 95(20):11792-7. [PubMed: 9751744]  [MGI Ref ID J:50111]

    Perez de Lema G; Maier H; Nieto E; Vielhauer V; Luckow B; Mampaso F; Schlondorff D. 2001. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12(7):1369-82. [PubMed: 11423566]  [MGI Ref ID J:109873]

    Ratkay LG; Tait B; Tonzetich J; Waterfield JD. 1994. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice. J Autoimmun 7(5):561-73. [PubMed: 7530961]  [MGI Ref ID J:20844]

    Sakic B; Kolb B; Whishaw IQ; Gorny G; Szechtman H; Denburg JA. 2000. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? J Neuroimmunol 111(1-2):93-101. [PubMed: 11063826]  [MGI Ref ID J:109885]

    Theofilopoulos AN; Dixon FJ. 1985. Murine models of systemic lupus erythematosus. Adv Immunol 37:269-390. [PubMed: 3890479]  [MGI Ref ID J:109952]

    Additional References

    Jabs DA; Prendergast RA; Rorer EM; Hudson AP; Whittum-Hudson JA. 2001. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci 42(11):2567-71. [PubMed: 11581200]  [MGI Ref ID J:72054]

    Sakic B; Szechtman H; Keffer M; Talangbayan H; Stead R; Denburg JA. 1992. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun 6(3):265-85. [PubMed: 1392101]  [MGI Ref ID J:2700]

    Verhagen C; Rowshani T; Willekens B; van Haeringen NJ. 1995. Spontaneous development of corneal crystalline deposits in MRL/Mp mice. Invest Ophthalmol Vis Sci 36(2):454-61. [PubMed: 7843914]  [MGI Ref ID J:24024]

    Xie C; Sharma R; Wang H; Zhou XJ; Mohan C. 2004. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 172(8):5047-55. [PubMed: 15067087]  [MGI Ref ID J:122988]

    Zheng QY; Johnson KR; Erway LC. 1999. Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 130(1-2):94-107. [PubMed: 10320101]  [MGI Ref ID J:54812]

    Health & husbandry

    Health & Colony Maintenance Information

    Animal Health Reports

    Room Number           AX9
    Room Number           RB04

    Colony Maintenance

    Breeding & HusbandryDue to the heightened healing which occurs in mice with the MRL genetic background, ear punch is not a good method for individual mouse identification in this strain.
    Mating SystemSibling x Sibling         (Female x Male)
    Diet Information LabDiet® 5K52/5K67

    Purchasing information

    Pricing, Supply Level & Notes, Controls, General Terms & Conditions

    Pricing

    Pricing for USA, Canada and Mexico shipping destinations View International pricing
    Weeks of AgePrice (US dollars $)Gender
    3-5 weeks $24.75Female
    $21.50Male
    6 weeks $26.80Female
    $23.55Male
    7 weeks $28.85Female
    $25.60Male
    8 weeks $30.90Female
    $27.65Male
    9 weeks $32.95Female
    $29.70Male
    10 weeks $35.00Female
    $31.75Male
    11 weeks $37.05Female
    $33.80Male

    Additional Supply Details

    Pricing for International shipping destinations View USA Canada and Mexico pricing
    Weeks of AgePrice (US dollars $)Gender
    3-5 weeks $32.20Female
    $28.00Male
    6 weeks $34.90Female
    $30.70Male
    7 weeks $37.60Female
    $33.40Male
    8 weeks $40.30Female
    $36.10Male
    9 weeks $43.00Female
    $38.80Male
    10 weeks $45.70Female
    $41.50Male
    11 weeks $48.40Female
    $44.20Male

    Additional Supply Details

    Supply Details

    Standard SupplyLevel 4. Up to 10 mice. Larger quantities or custom orders arranged upon request. Expected delivery up to one to three months.
    Supply Notes
    • Shipped at a specific age in weeks. Mice at a precise age in days, littermates and retired breeders are also available.
    • Strains that must be genotyped are not available until five to seven weeks of age.
    • Genomic DNA is available for this strain from the Mouse DNA Resource.

    Control Information

       
       This strain is a control for 000485 MRL/MpJ-Faslpr/J and 002983 MRL.CBAJms-Faslpr-cg/J.
     
      Considerations for Choosing Controls
      USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains.
      International - Control Pricing Information for Genetically Engineered Mutant Strains.

    Payment Terms and Conditions

    Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.


    See Terms of Use tab for General Terms and Conditions


    The Jackson Laboratory's Genotype Promise

    The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
    Ordering and Purchasing Information

          Purchasing Information
          JAX® Mice Orders
          Surgical Services

    Contact Information
    Orders & Technical Support
    Tel: 1-800-422-6423 or 1-207-288-5845
    Fax: 1-207-288-6150
    Technical Support Email Form

    Terms of Use

    Terms of Use


    General Terms and Conditions


    Contact information

    General inquiries

    Contracts Administration

    phone:207-288-6470
    fax:207-288-6655

    JAX® Mice, Products & Services Conditions of Use

    "MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCTS" means biological materials supplied by JACKSON, and their derivatives. "RECIPIENT" means each recipient of MICE, PRODUCTS, or services provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than the internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE or PRODUCTS from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON's prior written authorization.

    No Warranty

    MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

    In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.

    No Liability

    In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

    MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

    The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.

    Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.


    (3.7)